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Abstract
Background: The studies reported here were conducted to assess the efficacy of ivermectin long-acting injection
(IVM LAI; IVOMEC® GOLD, Merial; 3.15 % w/v ivermectin) for the treatment and control of natural infestations of
cattle by Hypoderma bovis and Hypoderma lineatum, which are the most economically important oestrid flies of
cattle in the northern hemisphere.
Methods: Cattle selected from herds with a history of Hypoderma infestation were grouped into blocks of three
(Italy, 33 cattle; Germany, 30 cattle) or two (USA, 16 cattle) animals each, on the basis of positivity at the pre-treatment
anti-Hypoderma antibody titres. Within each block, animals were randomly allocated to one of the following treatment
regimens: saline (control); IVM LAI, administered at the predicted time of occurrence of first-instar larvae (Italy, Germany,
USA); IVM LAI, administered at the predicted time of occurrence of second- and/or third-instar larvae (Italy, Germany).
All treatments were administered by subcutaneous injection in correspondence of the area anterior to the shoulder at
1 ml/50 kg body weight, which corresponds to 630 mcg IVM/kg for IVM LAI.
Results: No Hypoderma larvae emerged from animals treated with IVM LAI, whereas live H. lineatum (Italy) or H. bovis
(Germany, USA) larvae were collected from saline-treated animals (P < 0.01). No adverse reactions to treatments were in
any of the animals enrolled in the study.
Conclusions: The results from this study demonstrate that ivermectin in a long-acting formulation is 100 % efficacious
in the treatment of cattle naturally infested by H. bovis and H. lineatum larvae at all stages of development. IVM LAI can,
therefore, be used as ‘prophylactic’ treatment for Hypoderma spp. infestations in absence of external evidence of their
presence and thus prior to skin and carcass damage, and as ‘therapeutic’ treatment, when warbles are already present.
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Background
The family Oestridae includes some 150 species of
dipteran flies whose larvae are obligate parasites living,
over weeks to months, in the tissues or organs of domestic
and wild animals and causing obligate myiases [1, 2]. The
oestrid genus Hypoderma includes seven species of flies,
of which three are known to cause bovine hypodermosis
(also known as cattle grub or warble fly infestation) in the
northern hemisphere, i.e. Hypoderma bovis, H. lineatum
and H. sinense. During the summer season, female flies lay
eggs; from these, first-instar larvae hatch to then migrate
over several months through the somatic tissues of the an-
imals via the oesophagus (H. lineatum, H. sinense) or the
perirachidian tissues (H. bovis). Larvae moult into second-
and third-instar larvae and form the typical subcutaneous
nodules under the skin in the dorsal and lumbar regions
of cattle (warbles) in late winter and spring [3, 4].
Though bovine hypodermosis does not induce signifi-
cant mortality and morbidity, this infestation affects the
productivity and welfare of animals, thus resulting in con-
siderable losses to the livestock industry arising from a
number of causes [2, 5, 6]. In addition, bovine Hypoderma
species may accidentally infest humans and seldom cause
severe conditions [7–9].
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Administration of systemically active insecticides, i.e.
topical formulations of organophosphates and products
with macrocyclic lactone compounds, kill Hypoderma
larvae during their migration through the animal’s body.
Since the early 1980s, the widespread use of broad-
spectrum parasiticides, particularly macrocyclic lactones,
led to a marked decrease in the prevalence of bovine
hypodermosis in many developed countries of the
northern hemisphere [10]. This resulted in successful
area-wide or national control programs. However, des-
pite the extensive control measures undertaken, sur-
veillance studies based on serum and milk serology, as
well as reports on clinical infestation of cattle and para-
siticide efficacy studies and/or description of human
cases published over the past 15 years, provide evidence
that residual populations of Hypoderma spp. are still
present in cattle in North America including Canada
and the USA, as well as in Europe, e.g. in Portugal,
Spain, France, Italy, Belgium, Switzerland, Germany,
Poland, Slovakia and Estonia [11–24]. In addition, bo-
vine hypodermosis is prevalent in several countries in
eastern and south eastern Europe including Belarus,
Russia, Romania, Serbia, Bosnia and Herzegovina,
Kosovo, Albania and Greece [25–33], and it is still en-
demic in resource-limited countries in northern Africa
and Asia [34–41].
Macrocyclic lactones are characterized by excellent ef-
ficacy against a broad spectrum of nematode endo- and
arthropod ectoparasites, including infestation with myia-
sis causing larvae of oestrid flies [42]. More recently, in-
jectable long-action macrocyclic lactone formulations
were authorized for use in cattle in several countries in-
cluding ivermectin long-acting injection (IVM LAI;
IVOMEC® GOLD, Merial) [43].
Earlier studies that reported IVM LAI is highly effica-
cious in the control of cattle infestations by larvae of the
neotropical oestrid fly, Dermatobia hominis [44, 45]. The
studies reported here were conducted to assess the
efficacy of IVM LAI for the treatment and control of
natural infestations of cattle by H. bovis and H. lineatum,
the economically most important oestrid flies of cattle in
the northern hemisphere.
Methods
The studies were designed in accordance with and con-
sistent to the World Association for the Advancement of
Veterinary Parasitology guidelines for evaluating the effi-
cacy of ectoparasiticides against myiasis causing para-
sites [46]. The studies were conducted in compliance
with VICH GL9, entitled Good Clinical Practice and with
the local legislation for animal welfare. The studies were
performed as blinded studies, i.e. all personnel involved
in collecting efficacy data were masked as to the assign-
ment of each animal to treatment groups.
Experimental animals
A total of 79 healthy beef cattle, weighing 121.5 to
386 kg at the start of the study (day -1 or day 0), and
aging approximately 5–21 months, were included in
three studies, conducted in Italy (Study 1), Germany
(Study 2) and the USA (Study 3). Animal descriptions
and details are presented in Table 1. The animals were
sourced from herds with a history of Hypoderma spp. in
the Basilicata region, Italy, Rhine Palatinate, Germany or
Wisconsin, USA. Animals had not been previously treated
with a macrocyclic lactone product and they were
previously exposed to Hypoderma spp. as confirmed
by the presence of anti-Hypoderma antibodies prior
to treatment.
All animals were handled with due regard to their
welfare and in compliance with Merial Institutional
Animal Care and Use Committee (IACUC) approvals,
any applicable local regulations, and requirements of
any local IACUC.
Table 1 Animal description and details




1, Italy Control (n = 11) Podolica pugliese, Podoloca cross, Romagnola 7 male, 26 female 5–9 132–332
IVM LAI L1c (n = 11)
IVM LAI L2/L3d (n = 11)
2, Germany Control (n = 10) Beef crossbred 10 male, 20 female 6–21 121.5–386
IVM LAI L1 (n = 10)
IVM LAI L2/L3 (n = 10)
3, USA Control (n = 8) Angus cross, Hereford cross 8 male castrate, 8 female 7–8 205.5–373
IVM LAI L1 (n = 8)
aSource of animals: Study 1: Basilicata, Italy; Study 2: Rhine Palatinate, Germany; Study 3: Wisconsin, USA
bControl = Saline; IVM LAI = ivermectin long-acting injection (IVOMEC® GOLD)
cTreatment during the L1 stage of development
dTreatment during the L2/L3 stages of development
Otranto et al. Parasites & Vectors  (2016) 9:551 Page 2 of 6
Experimental design
A randomized block design based on pre-treatment anti-
Hypoderma antibody levels was used; each individual
animal represented the experimental unit in each study.
Eleven or ten blocks of three (Studies 1 and 2) or eight
blocks of two (Study 3) cattle each were formed sequen-
tially based on decreasing pre-treatment anti-Hypo-
derma antibody level results (Studies 1 and 2: Pourquier®
ELISA Bovine Hypodermosis/Hypo Serums; Montpellier,
France; Study 3: ELISA test as described by Colwell et al.
[47]. Within each block, animals were randomly allo-
cated to 1 of the following treatments: saline (control)
(Studies 1, 2 and 3); IVM LAI (3.15 % w/v ivermectin in
a LAI formulation; IVOMEC® GOLD, Merial), adminis-
tered in correspondence of the predicted occurrence of
first-instar larvae (Studies 1, 2 and 3); IVM LAI, admin-
istered in correspondence of the predicted occurrence of
second- and/or third-instar larvae (Studies 1 and 2).
Cattle were either kept indoors and housed in
loose-pens (Study 1) or individually stanchioned (Study 2)
per block, or were kept as one group in a fenced dry lot
(Study 3). Animals were fed as per local practice and were
water was provided ad libitum.
The studies commenced either in November (Study 1)
or in December (Studies 2 and 3). Treatments, saline as
well as IVM LAI, were administered at 1 ml/50 kg body-
weight once in correspondence of the predicted occur-
rence of Hypoderma spp. first-instar larvae (day 0: all
studies) or once in correspondence of the predicted oc-
currence of second- and third-instar larvae (day 84:
Study 1; day 125: Study 2) by subcutaneous injection in
an area anterior to the shoulder using commercial dis-
posable syringes and needles. All cattle were observed
hourly for 4 h post-treatment and thereafter once daily
throughout the course of the studies for health problems
or adverse drug reactions. Animals were weighed prior
to treatments (days -1 and 84: Study 1; days 0 and 125:
Study 2; day -1: Study 3) for dose calculation. Cattle
were inspected for warbles starting 40 (Studies 1 and 2)
or 28 (Study 3) days following day 0 treatment and then at
intervals no greater than every 2 weeks until sufficient
warbles were detected to warrant a second treatment in
correspondence of the predicted occurrence of second-
and third-instar larvae. Thereafter, cattle were inspected,
and mature Hypoderma spp. larvae were collected, viabil-
ity was determined and larvae were identified to species
according to published keys [48, 49], unless identification
was impossible because of decomposition prior to collec-
tion. Cattle were examined until the end of the studies, i.e.
emergence of larvae could no longer be detected.
Data analysis
Hypoderma live larval counts were transformed to
the natural logarithm of (count + 1) for calculation of
geometric means. IVM LAI treatment groups were
compared (separately) to the saline-treated (control)
group using the Wilcoxon rank sum test. A 2-sided
test was used at the significance level of 0.05. Analyses
were performed using SAS® Version 8.2. Efficacy was
calculated as 100[(C-T)/C], where C is the geometric
mean for the saline-treated (control) group and T is the
geometric mean for the IVM LAI treated group.
Results
All identifiable larvae collected in Study 1 were identified
as H. lineatum, whereas all larvae collected in Studies 2
and 3 were identified as H. bovis.
Sufficient warbles to warrant treatment against sec-
ond- and third-instar Hypoderma larvae were detected
on study days 84 (Study 1: 3 to 49 warbles in 10/11 ani-
mals) and 125 (Study 2: 1 to 16 warbles in 8/10 animals),
respectively. In correspondence of these days, 3 to 41
warbles were counted on 9/11 control animals in Study 1,
and 1 to 14 warbles on 7/10 control animals in Study 2.
Following treatments against second- and third-instar
larvae appearance, the number of warbles regressed to
one warble each within 6 or 10 weeks in Study 2 and
Study 1, respectively. At the inspection, the warbles con-
tained a dead third-instar Hypoderma larva (Study 1) or
granulomatous tissue (Study 2). No Hypoderma spp. lar-
vae emerged from any of the cattle treated in corres-
pondence to the predicted occurrence of first-instar
larvae or when the Hypoderma spp. larvae were in the
second and/or third stage.
Forty-nine live H. lineatum larvae and 23 and 66 live
H. bovis larvae were collected from the saline-treated
(control) animals in Studies 1, 2 and 3, respectively,
emergence of larvae could no longer be observed (study
days 158, 168, or 183 in Studies 1, 2 and 3, respectively).
Cattle treated with IVM LAI in correspondence to the
predicted occurrence of Hypoderma spp. first or second
and third-instar larvae had significantly fewer H. linea-
tum or H. bovis larvae emerging and/or expressed than
the saline-treated (control) animals (Table 2). The effi-
cacy of IVM LAI against larval stages of H. lineatum or
H. bovis was 100 % (Table 2).
Animals were reported as normal during hourly observa-
tions for 4 h post-treatment, indicating that the treatment
(either IVM LAI or saline) was well accepted. There were
no drug related health problems or adverse drug events
observed at any time during the studies.
Discussion
The results presented herein demonstrate that ivermectin
in a long-acting formulation is 100 % efficacious in the
treatment of cattle naturally infested with H. bovis and H.
lineatum larvae. IVM LAI can, therefore, be used as
‘prophylactic’ treatment for Hypoderma spp. infestations,
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i.e. in absence of external evidence of their presence and
prior to carcass and skin damage, and as ‘therapeutic’
treatment, e.g. when warbles are already present. Similar
results were reported previously by several authors
who tested other commercial formulations containing
ivermectin and other compounds of the macrocyclic
lactone family (reviewed by [23, 42]).
Serodiagnosis of hypodermosis was used to select the
study animals, as this is the only way to detect infested
animals well before the appearance of the warbles; how-
ever, there is no correlation between titer levels and in-
tensity of infestation [50–52]. Although anti-Hypoderma
antibody positive animals were enrolled in the studies,
warbles were only detected in 80 % of the saline-treated
animals (Studies 1, 2 and 3; n = 29), as well as in the ani-
mals subjected to treatment in correspondence of the
predicted occurrence of second- and/or third-instar lar-
vae (Studies 1 and 2; n = 21), with infestation rates of
86.4, 75 and 75 % in Studies 1, 2 and 3, respectively. The
80 % overall infestation rate is consistent with observa-
tions from previous studies where the development of
warbles was recorded in 81.4 % of the animals which
had tested positive for anti-Hypoderma antibodies [23].
Similarly, numbers of warbles on the animals and num-
bers of Hypoderma larvae collected from the control an-
imals in this study were similar to those reported in the
same studies [23]. As discussed earlier, these findings are
in line with the predictive value of the available ELISAs
but may also reflect, at least in part, the high mortality
of larvae in Hypoderma spp. infestations [23]. Although
ELISA serology may over-estimate the percentage of
cattle that develop warbles (clinical hypodermosis), it is
considered to be a sensitive indication of exposure of
cattle to grub infestation and thus a suitable measure for
detection of low level, persistent bovine Hypoderma spp.
populations [22].
Conclusions
With respect to the efficacy profile of IVM LAI, which
provides effective control of nematode infections in cat-
tle for up three months [53, 54] and the high sensitivity
of Hypoderma spp. to macrocyclic lactones in general
[42] and ivermectin in particular [55, 56], it can be as-
sumed that IVM LAI while the flies are at the adult de-
velopmental stage will also provide protection against
cattle Hypoderma spp. larval infestation. Hypoderma
spp. populations are known to (re)generate promptly if
eradication or control measures are incomplete or if re-
introduction occurs [57–60]. Thus, these parasites should
not be ignored and further attention should be paid to cat-
tle parasite management programs not only in regions
where bovine hypodermosis is widespread and an import-
ant economic burden for the cattle industry, but also in
regions where these parasites occur (currently) at very low
prevalence with patchy distribution.
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Live Hypoderma lineatum larvae
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Live Hypoderma bovis larvae
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IVM LAI L1 (day 0) 0/8 0 100 2.8387 0.0045
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dEfficacy = 100× (GM Control – GM IVM LAI/GM Control)
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